Methanol ulc ms cc sfc grade

Manufactured by Biosolve

Sourced in Netherlands

Methanol (ULC/MS-CC/SFC grade) is a high-purity solvent suitable for use in ultra-low-carry applications, mass spectrometry, capillary chromatography, and supercritical fluid chromatography.

Automatically generated - may contain errors

Lab products found in correlation

Dimethyl sulfoxide (dmso), by Merck Group (2 mentions) Acetonitrile, by Merck Group (2 mentions) 2 propanol, by Merck Group (2 mentions)

Spelling variants of this product

Methanol (160 citations) ULC/MS grade (9 citations) Methanol ULC/MS grade (8 citations) ULC/MS (4 citations) MS-CC/SFC grade) (2 citations) Methanol (ULC-MS) (2 citations)

3 protocols using methanol ulc ms cc sfc grade

Quantitative MALDI-MS Sample Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Methanol (ULC/MS-CC/SFC grade) and chloroform (HPLC grade) were purchased from Biosolve BV (Valkenswaard, The Netherlands). All MALDI matrices, 2, 5-dihydroxybenzoic acid ≥ 98% (DHB), norharmane, N-(1-naphthyl) ethylenediamine dihydrochloride (NEDC), carboxymethyl cellulose (CMC) and amino acid standards were purchased from Sigma Aldrich. Conductive indium tin oxide (ITO)–coated glass slides were purchased from Delta Technologies (Loveland, CO, USA), TAHS (p-N,N,N- trimethylamonioanilyl N-hydroxysuccinimidylcarbamate iodide) was synthesized as described elsewhere (Arts et al. 2017 (link)).

Vats M., Cillero-Pastor B., Flinders B., Cuypers E, & Heeren R.M. (2023). Mass spectrometry imaging reveals flavor distribution in edible mushrooms. Journal of Food Science and Technology, 61(5), 888-896.

+ Open protocol

+ Expand

Quantitative Analysis of OSIM and PAZO

Check if the same lab product or an alternative is used in the 5 most similar protocols

OSIM (free base, purity 95%) and pazopanib (PAZO) (free base, purity 98%) were purchased from Toronto Research Chemicals (Toronto, Ontario, Canada) . Methanol (ULC/MS-CC/SFC grade) was purchased from Biosolve (Valkenswaard, the Netherlands). Acetonitrile (≥99.9%), 2-propanol (≥99.8%) and dimethylsulfoxide (DMSO, ≥99.0%) were obtained from Merck (Darmstadt, Germany). Drug-free serum (frozen, no additives) was purchased from Sanquin (Amsterdam, the Netherlands).

van Veelen A., van Geel R., de Beer Y., Dingemans A.M., Stolk L., Ter Heine R., de Vries F, & Croes S. (2020). Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability results. Biomedical chromatography : BMC, 34(4).

+ Open protocol

+ Expand

Simultaneous Quantification of TKI Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols

Alectinib (free base purity [FBP] = 98%), crizotinib (FBP = 98%), erlotinib (FBP = 97%), gefitinib (FBP = 98%), crizotinib-D5 (chemical purity 97%, isotopic purity 99,2%), erlotinib-D6 (FBP = 98%) and gefitinib-D3 (chemical purity = 98%, isotopic purity = 99,7%) were purchased from Bio Connect (Huissen, The Netherlands). Methanol (ULC/MS-CC/SFC grade) was purchased from Biosolve (Valkenswaard, the Netherlands). Acetonitrile (≥99.9%), 2-propanol (≥99.8%) and dimethylsulfoxide (DMSO, ≥99.0%) were obtained from Merck (Darmstadt, Germany). Ammonium-acetate (Normapur) was purchased from VWR (Leuven, Belgium). Sodium-citrate plasma (frozen, no additives) was purchased from Sanquin (Amsterdam, the Netherlands). K2-EDTA whole blood, and subsequently, K2-EDTA plasma were obtained from volunteers.

van Veelen A., van Geel R., Schoufs R., de Beer Y., Stolk L.M., Hendriks L.E.L, & Croes S. (2021). Development and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run. Biomedical chromatography : BMC, 35(12).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!